For: | Bower JAJ, O'Flynn L, Kakad R, Aldulaimi D. Effect of inflammatory bowel disease treatments on patients with diabetes mellitus. World J Diabetes 2021; 12(8): 1248-1254 [PMID: 34512890 DOI: 10.4239/wjd.v12.i8.1248] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v12/i8/1248.htm |
Number | Citing Articles |
1 |
Miao-Miao Sang, Zi-Lin Sun, Tong-Zhi Wu. Inflammatory bowel disease and diabetes: Is there a link between them?. World Journal of Diabetes 2022; 13(2): 126-128 doi: 10.4239/wjd.v13.i2.126
|
2 |
Samrat Ray, Anila Yousuf, Atit Dharia, Ghassan Ayoub, Catherine Parmentier, Andrea Norgate, Jeffrey Schiff, Chaya Shwaartz, Markus Selzner, Trevor W. Reichman. Outcomes of pancreas transplantation in patients with underlying inflammatory bowel disease: a retrospective case series. Annals of Medicine & Surgery 2023; 85(4): 732 doi: 10.1097/MS9.0000000000000408
|
3 |
Qiu‐Ping Xiao, You‐Bao Zhong, Zeng‐Ping Kang, Jia‐Qi Huang, Wei‐Yan Fang, Si‐Yi Wei, Jian Long, Shan‐Shan Li, Hai‐Mei Zhao, Duan‐Yong Liu. Curcumin regulates the homeostasis of Th17/Treg and improves the composition of gut microbiota in type 2 diabetic mice with colitis. Phytotherapy Research 2022; 36(4): 1708 doi: 10.1002/ptr.7404
|